Institute of Tropical Medicine, Universitätsklinikum Tübingen, Wilhelmstrasse 27, 72074, Tübingen, Germany.
Vietnamese-German Center for Medical Research, VG-CARE, Hanoi, Vietnam.
Ann Clin Microbiol Antimicrob. 2022 Sep 5;21(1):39. doi: 10.1186/s12941-022-00530-6.
The aim of the present study is to compare the performance of 16S rRNA Nanopore sequencing and conventional culture in detecting infectious pathogens in patients with suspected meningitis in a resource-limited setting without extensive bioinformatics expertise.
DNA was isolated from the cerebrospinal fluid (CSF) of 30 patients with suspected bacterial meningitis. The isolated DNA was subjected to 16S sequencing using MinION™. The data were analysed in real time via the EPI2ME cloud platform. The Nanopore sequencing was done in parallel to routine microbiological diagnostics.
Nanopore sequencing detected bacterial pathogens to species level in 13 of 30 (43%) samples. CSF culture showed 40% (12/30) positivity. In 21 of 30 patients (70%) with suspected bacterial meningitis, both methods yielded concordant results. About nine of 30 samples showed discordant results, of these five were false positive and four were false negative. In five of the culture negative results, nanopore sequencing was able to detect pathogen genome, due to the higher sensitivity of the molecular diagnostics. In two other samples, the CSF culture revealed Cryptococcus neoformans and Streptococcus pneumoniae, which were not detected by Nanopore sequencing. Overall, using both the cultures and 16S Nanopore sequencing, positivity rate increased from 40% (12/30) to 57% (17/30).
Next-generation sequencing could detect pathogens within six hours and could become an important tool for both pathogen screening and surveillance in low- and middle-income countries (LMICs) that do not have direct access to extensive bioinformatics expertise.
本研究旨在比较 16S rRNA 纳米孔测序和传统培养在资源有限、缺乏广泛生物信息学专业知识的环境中检测疑似脑膜炎患者感染性病原体的性能。
从 30 例疑似细菌性脑膜炎患者的脑脊液(CSF)中提取 DNA。分离的 DNA 采用 MinION™进行 16S 测序。通过 EPI2ME 云平台实时分析数据。纳米孔测序与常规微生物诊断平行进行。
纳米孔测序在 30 个样本中的 13 个(43%)样本中检测到细菌病原体的种水平。CSF 培养显示阳性率为 40%(12/30)。在 30 例疑似细菌性脑膜炎患者中,21 例(70%)两种方法的结果一致。大约 30 个样本中有 9 个结果不一致,其中 5 个为假阳性,4 个为假阴性。在 5 个培养阴性结果中,纳米孔测序能够检测到病原体基因组,这是由于分子诊断的灵敏度更高。在另外两个样本中,CSF 培养显示出新型隐球菌和肺炎链球菌,这两种菌均未被纳米孔测序检测到。总的来说,同时使用培养和 16S 纳米孔测序,阳性率从 40%(12/30)增加到 57%(17/30)。
下一代测序可在 6 小时内检测病原体,对于无法直接获得广泛生物信息学专业知识的中低收入国家(LMICs),它可能成为病原体筛查和监测的重要工具。